Wolverine Trading
FLNA

Wolverine Trading’s Filana Therapeutics FLNA Stock Holding History

Wolverine Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-73,600
Closed -$129K – 6104
2025
Q2 		$129K Sell
73,600
-1,100
-1% -$1.96K ﹤0.01% 4096
2025
Q1 		$123K Sell
74,700
-25,300
-25% -$63.8K ﹤0.01% 4159
2024
Q4 		$240K Sell
100,000
-13,700
-12% -$241K ﹤0.01% 4292
2024
Q3 		$3.24M Buy
113,700
+94,700
+498% +$2.18M ﹤0.01% 1342
2024
Q2 		$235K Sell
19,000
-4,600
-19% -$97K ﹤0.01% 3677
2024
Q1 		$479K Buy
+23,600
New +$544K ﹤0.01% 2886
2023
Q4 		– Sell
-64,600
Closed -$1.07M – 5124
2023
Q3 		$1.07M Buy
64,600
+24,400
+61% +$484K ﹤0.01% 2067
2023
Q2 		$951K Sell
40,200
-9,600
-19% -$231K ﹤0.01% 2045
2023
Q1 		$1.2M Sell
49,800
-45,300
-48% -$1.26M ﹤0.01% 1750
2022
Q4 		$2.81M Buy
+95,100
New +$3.42M ﹤0.01% 1196
2022
Q3 		– Sell
-84,500
Closed -$2.51M – 5233
2022
Q2 		$2.51M Sell
84,500
-2,100
-2% -$53K ﹤0.01% 1216
2022
Q1 		$3.34M Sell
86,600
-19,900
-19% -$843K ﹤0.01% 1350
2021
Q4 		$4.66M Sell
106,500
-63,300
-37% -$3.32M 0.01% 1196
2021
Q3 		$10.6M Buy
169,800
+63,200
+59% +$5.27M 0.01% 768
2021
Q2 		$8.85M Buy
106,600
+27,700
+35% +$1.48M 0.01% 759
2021
Q1 		$3.47M Buy
+78,900
New +$3.1M 0.01% 1407

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Wolverine Trading's FLNA Position: Q3 2024 in Review

Wolverine Trading sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 18,733 shares — an estimated $431K sold.

Wolverine Trading first reported a position in FLNA in Q3 2016 and held it in 9 quarters. The position peaked at $2.03M in Q3 2021. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

  • Wolverine Trading reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 18,733 Filana Therapeutics shares in Q3 2024, an estimated $431K.
  • Wolverine Trading first reported a position in Filana Therapeutics in Q3 2016 and held it in 9 quarters.
  • Wolverine Trading's Filana Therapeutics position peaked at $2.03M in Q3 2021.
  • 161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.